SXTC Stock Price, Chart, Stats & News

China SXT Pharmaceuticals, Inc.
Save
China SXT Pharmaceuticals, Inc. (SXTC) does not currently pay a dividend.
1.37M
Market cap
0.92x
Current P/E
–
Forward P/E
SXTC chart
Fundamentals
Gross margin | 22.63% |
Operating margin | -178.06% |
Pretax margin | -218.85% |
Net margin | -218.85% |
Effective tax rate | – |
ROA | -11.01% |
ROE | -17.55% |
D/E | 0.06x |
Interest coverage ratio | -4.24x |
SXTC valuation
P/E | 0.92x |
P/S | 0.84x |
P/B | 0.16x |
P/CF | -1.91x |
P/FCF | -0.66x |
P/OCF | -1.91x |
PEG | 0.00x |
EV multiple | -9.11x |
About
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands.
Similar securities
Based on sector and market capitalization
Report issue





